Posted on 1/11/21
Qualitas Health/iwi Raises $10M
Plant-based omega-3 pioneers, Qualitas Health, DBA iwi, announces it has secured $10 million in venture funds at a $73million post-money valuation. The investment round is being . . .
Posted on 1/11/21
Nike Invests $500K in Black Girl Ventures
Nike is investing $500,000 into D.C.-based Black Girl Ventures, the corporation announced on Friday
Posted on 1/11/21
CVC Growth Fund Announces Successful Exit of Kount in $640M Deal
CVC Capital Partners announced today that the CVC Growth Fund has signed a definitive agreement to sell Kount Inc., a provider of Artificial Intelligence (AI)- driven fraud . . .
Posted on 1/10/21
JMI Equity Portfolio Company Bloomerang Acquires Kindful
Bloomerang, a leader in cloud-based donor management and fundraising software for small and mid-size nonprofits, today announced
Posted on 1/8/21
Carrum Health Raises $40M in Series A Funding
Carrum Health, a San Francisco, CA-based digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform, closed a $40m Series . . .
Posted on 1/8/21
Outstanding Foods Closes $10M Series A Financing
Outstanding Foods, a Los Angeles, CA-based maker of plant-based snacks, raised $10m in Series A financing.
Posted on 1/8/21
MANA Therapeutics Launches with $35 Million Series A Financing
WALTHAM, Mass.--(BUSINESS WIRE)--MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announced a $35 million Series A financing. . . .
Posted on 1/8/21
Affinivax Announces $226 Million Series C Financing
Affinivax, Inc., a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS platform, today announced the closing of a . . .
Posted on 1/8/21
T. Rowe Price Joins $226 Million Series C for Affinivax
Affinivax, Inc., a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS platform, today announced the closing of a . . .
Posted on 1/7/21
University System of Maryland Momentum Fund Joins $6.75M Series A for Voxy Engen
Voxy EnGen, a NYC-based language upskilling platform provider, secured $6.75m in Series A financing
Posted on 1/7/21
Voxy EnGen Raises $6.75M in Series A Funding
Voxy EnGen, a NYC-based language upskilling platform provider, secured $6.75m in Series A financing
Posted on 1/7/21
Bessemer Leads $23M Series B for Aspen RxHealth
Aspen RxHealth, whose first of its kind clinical pharmacy model developed by pharmacists for pharmacists delivers value for health plans and risk-bearing providers
Posted on 1/7/21
CARISMA Therapeutics Completes $47 Million Series B Funding
CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for . . .
Posted on 1/7/21
IsoPlexis Announces $135 Million Series D Led by Perceptive Advisors
IsoPlexis, the leader in single-cell functional proteomics, today announced a $135 million Series D financing comprised of $85 million in equity securities and a $50 million . . .
Posted on 1/7/21
Hello Ralphie Closes $1M Seed Round
Hello Ralphie, the veterinary telemedicine startup, has announced the closing of its $1M seed round of funding through primary investments from HearstLab and WPMC Fund.
Posted on 1/7/21
Glia Raises $78 Million in Series C Funding Led by Insight Partners
Glia, a leading provider of Digital Customer Service, today announced that it has raised $78 million in Series C funding, bringing Glia's total fundraising to $107 . . .
Posted on 1/7/21
Curlsmith Closes Series A Funding led by BFG Partners
Curlsmith, a premium haircare brand specializing in textured hair, announced today that it has closed its Series A financing led by BFG Partners. The funding will . . .
Posted on 1/7/21
Werewolf Therapeutics Completes $72 Million Series B Financing
Werewolf Therapeutics, Inc., an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments, today announced the completion of its $72 million Series B financing.
Posted on 1/7/21
Kira Pharmaceuticals Closes $53.5 Million Series B+ Financing
Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed $53.5 . . .
Posted on 1/7/21
Quantum Xchange Closes $13.5 million Series A Funding
Quantum Xchange, a leader in quantum-safe products and services for crypto agility and quantum readiness, today announced that it has completed the initial close on $13.5 . . .
Posted on 1/7/21
Apex Secures $75 Million Upsized Financing from Helaba
Apex Clean Energy today announced that it has upsized a letter of credit facility from Helaba. The financing agreement, originally announced in 2019, was increased from . . .
Posted on 1/7/21
Lacework Closes a $525 Million Growth Round
Lacework, the security platform for the cloud generation, today announced a $525 million growth round with a valuation of over $1 billion. Led by Sutter Hill . . .
Posted on 1/7/21
LifeMine Therapeutics Raises $50 Million Series B
LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining fungal biodiversity to develop mechanistically and structurally novel therapeutics, today announced a $50 million
Posted on 1/7/21
Scorpion Therapeutics Raises $162M In Series B
Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closing of an oversubscribed Series B financing, which raised $162 million.
Posted on 1/7/21
Abcuro Raises $42 Million in Series A-1
Abcuro, Inc., a clinical-stage biotechnology company developing therapies for autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells
